Company Filing History:
1 out of 295 
2 out of 832,812 Years Active: 2017-2018
Title: Claudia Penafuerte: Innovator in Immunotherapy
Introduction
Claudia Penafuerte is a prominent inventor based in Montreal, Canada. She has made significant contributions to the field of immunotherapy, particularly through her innovative research and development of novel compounds.
Latest Patents
Claudia holds 3 patents, with her latest inventions focusing on TC-PTP inhibitors as antigen-presenting cell (APC) activators for immunotherapy. These inventions encompass a novel class of compounds that inhibit the TC-PTP enzyme. The pharmaceutical compositions developed include these compounds and methods for treating or preventing TC-PTP mediated diseases, including cancer. Her work emphasizes the activation of dendritic cells for applications in immunotherapeutic treatments.
Career Highlights
Throughout her career, Claudia has worked at notable institutions, including the Royal Institution for the Advancement of Learning/McGill University. Her research has been pivotal in advancing the understanding and treatment of diseases through innovative therapeutic approaches.
Collaborations
Claudia has collaborated with esteemed colleagues, including Michel L. Tremblay and Matthew Feldhammer, contributing to a rich exchange of ideas and advancements in her field.
Conclusion
Claudia Penafuerte's work in immunotherapy exemplifies the impact of innovative research on healthcare. Her contributions continue to pave the way for new treatments and therapies that can significantly improve patient outcomes.